STOCK TITAN

HealthEquity (NASDAQ: HQY) founder covers tax bill with shares

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HEALTHEQUITY, INC. founder and vice chairman Stephen Neeleman reported a tax-withholding disposition of 9,292 shares of common stock at $82.5264 per share on March 31, 2026. These shares were withheld to satisfy tax obligations, not sold in an open-market transaction.

After this event, he holds 141,227 common shares directly. Additional common stock is held indirectly through a family trust, his spouse, and a family holding company, with portions of beneficial ownership disclaimed as described in the footnotes. He also retains vested stock options over tens of thousands of shares with exercise prices between $41.28 and $73.61 that expire from 2027 through 2029.

Positive

  • None.

Negative

  • None.
Insider Neeleman Stephen
Role FOUNDER AND VICE CHAIRMAN
Type Security Shares Price Value
Tax Withholding Common Stock 9,292 $82.5264 $767K
holding Stock Option (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 141,227 shares (Direct); Stock Option (right to buy) — 19,897 shares (Direct); Stock Options (right to buy) — 14,228 shares (Direct); Common Stock — 409,735 shares (Indirect, See footnote)
Footnotes (1)
  1. Shares held of record by the Stephen and Christine Neeleman Trust. The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. The option is immediately exercisable.
Shares withheld for taxes 9,292 shares Tax-withholding disposition at $82.5264 on March 31, 2026
Tax-withholding price $82.5264 per share Price for 9,292-share F-code disposition
Direct shares after transaction 141,227 shares Common stock directly held after March 31, 2026
Indirect trust holding 409,735 shares Common stock held through Stephen and Christine Neeleman Trust
Stock options at $41.28 19,897 underlying shares Immediately exercisable; expire March 27, 2027
Stock options at $61.72 14,228 underlying shares Immediately exercisable; expire March 27, 2028
Stock options at $73.61 15,337 underlying shares Immediately exercisable; expire March 26, 2029
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Stock Option (right to buy financial
"security_title": "Stock Option (right to buy)""
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein"
Section 16 regulatory
"for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neeleman Stephen

(Last)(First)(Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100

(Street)
DRAPER UTAH 84020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
FOUNDER AND VICE CHAIRMAN
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026F9,292D$82.5264141,227D
Common Stock409,735ISee footnote(1)
Common Stock140,000ISee footnote(2)
Common Stock203,000ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$41.28 (4)03/27/2027Common Stock19,89719,897D
Stock Options (right to buy)$61.72 (4)03/27/2028Common Stock14,22814,228D
Stock Options (right to buy)$73.61 (4)03/26/2029Common Stock15,33715,337D
Explanation of Responses:
1. Shares held of record by the Stephen and Christine Neeleman Trust.
2. The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
3. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
4. The option is immediately exercisable.
/s/ Stephen Neeleman04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did HealthEquity (HQY) founder Stephen Neeleman report in this Form 4?

Stephen Neeleman reported a tax-withholding disposition of 9,292 shares of HealthEquity common stock at $82.5264 per share. The shares were withheld to cover tax obligations related to equity compensation, rather than sold in an open-market trade.

Did Stephen Neeleman sell HealthEquity (HQY) shares on the open market?

No, the Form 4 shows a tax-withholding disposition of 9,292 shares, coded as an F transaction. This means shares were delivered to satisfy tax liabilities, not voluntarily sold on the open market for investment or liquidity purposes.

How many HealthEquity (HQY) shares does Stephen Neeleman hold directly after this filing?

Following the tax-withholding transaction, Stephen Neeleman directly holds 141,227 shares of HealthEquity common stock. This direct position reflects his remaining ownership after the 9,292 shares were withheld to satisfy tax obligations tied to his equity compensation.

What indirect HealthEquity (HQY) holdings are associated with Stephen Neeleman?

The filing lists indirect holdings of 409,735, 140,000, and 203,000 common shares through a family trust, spouse, and family LLC. Footnotes state he disclaims beneficial ownership of some of these shares, except to the extent of any pecuniary interest.

What stock options on HealthEquity (HQY) does Stephen Neeleman retain?

Neeleman holds vested stock options over 19,897 shares at $41.28, 14,228 shares at $61.72, and 15,337 shares at $73.61. These options are immediately exercisable and expire between March 2027 and March 2029, according to the filing.

How significant is the reported HealthEquity (HQY) tax-withholding transaction?

The transaction covers 9,292 shares withheld for taxes, while Neeleman retains 141,227 shares directly plus substantial indirect holdings and options. Because it is a tax-related withholding rather than an open-market sale, it is generally viewed as a routine administrative event.